Hepatocyte Growth Factor and Interleukin-6 in Combination With Prostate Volume Are Possible Prostate Cancer Tumor Markers in Patients With Gray-Zone PSA Levels

Prostate Cancer and Prostatic Diseases - United Kingdom
doi 10.1038/sj.pcan.4501006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Hepatocyte Growth Factor and Interleukin-6 in Prostate Cancer Bone Metastasis

2003English

Peripheral Zone Prostate Cancer in Patients With Elevated PSA Levels and Low Free-To-Total PSA Ratio: Detection With MR Imaging and MR Spectroscopy

Radiology
Nuclear MedicineRadiologyImaging
2009English

PSA Levels and Prognosis in Patients With Hormone-Refractory Prostate Cancer Treated With Low-Dose Dexamethasone

Japanese Journal of Urology
Urology
2001English

Prostate Cancer Screening With PSA: "Aequanimitas"

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2013English

Tumor Volume Associated With Recurrence in Prostate Cancer Patients With Seminal Vesicle Invasion

Open Journal of Urology
2012English

The Relationship of PSA, PSAD and Clinicopathological Stage in Patients With Prostate Cancer

Chinese Journal of Clinical Oncology
Cancer ResearchOncology
2007English

Plasma Carotenoids and Tocopherols in Relation to Prostate-Specific Antigen (PSA) Levels Among Men With Biochemical Recurrence of Prostate Cancer

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2015English

Relationship Aggressiveness of Prostate Cancer With Tumor-Associated Serum Markers

Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994)
Medicine
2019English

Metastatic Prostate Cancer With Highest Reported PSA Level

Acta Medica Marisiensis
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy